Multiple Manufacturers

CEFOXITIN

Manufacturer:

Multiple Manufacturers

Cefoxitin HCPCS:

J0694

HCPCS Code Descriptor:

Injection, cefoxitin sodium, 1 gm

Category:

J Code

Cefoxitin NDCs:

44567-0247-10, 00264-3125-11, 63323-0343-66, 00143-9876-10, 25021-0111-99, 44567-0246-25, 00143-9877-25, 63323-0342-25, 44567-0245-25, 00143-9878-25, 63323-0341-25, 63323-0342-29, 44567-0246-85, 25021-0110-20, 63323-0341-29, 44567-0245-85, 25021-0109-10, 00264-3123-11

Primary Type:

Antibiotic

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00264-3125-11, 63323-0343-66, 44567-0246-85, 44567-0245-85, 00264-3123-11

About Cefoxitin:

CEFOXITIN is an Antibiotic drug manufactured by Hikma and administered via the Intravenous route of administration. The J Code: J0694 is aligned to the drug CEFOXITIN.

ACCESS PRICING AND MORE BY REGISTERING

J0694 Added Date:

January 1, 1992

J0694 Effective Date:

January 1, 1997

J0694 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cefoxitin billing and coding information.
Our team did not identify a source for Cefoxitin patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for CEFOXITIN
Our team has not yet identified a source of side effects information for CEFOXITIN. Please check back in a few weeks.